| Bailey Allen, | |
|
20 E Piccadilly St Ste 11&14, Winchester, VA 22601-3971 | |
| (877) 407-3422 | |
| (877) 407-4329 |
| Full Name | Bailey Allen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 20 E Piccadilly St Ste 11&14, Winchester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780468256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119010066 (Virginia) | Primary |
| Provider Name | Fox Rehabilitation Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1609814755 PECOS PAC ID: 1355347410 Enrollment ID: O20090811000339 |
News Archive
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the August 19 issue of Nature and conducted by doctors and researchers at Nationwide Children's Hospital using blood profiling techniques to understand infections.
MedAssets, Inc. announced today that Jackson Health System has selected the Company as its strategic partner to implement MedAssets' transformational approach to significantly lower supply costs, drive operational efficiencies and engage physicians in the cost and clinical utilization management improvement process.
Ching-Ling (Ellen) Lien, PhD, an investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded nearly $1.7 million, over a four year period, from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the molecular and cellular mechanisms of the heart's circulatory system.
Pfizer Inc. announced today top-line results from ORAL Start (A3921069), a Phase 3 study of the investigational agent tofacitinib, a novel, oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bailey Allen, 7 Carnegie Plz, Cherry Hill, NJ 08003-1000 Ph: (877) 407-3422 | Bailey Allen, 20 E Piccadilly St Ste 11&14, Winchester, VA 22601-3971 Ph: (877) 407-3422 |
News Archive
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the August 19 issue of Nature and conducted by doctors and researchers at Nationwide Children's Hospital using blood profiling techniques to understand infections.
MedAssets, Inc. announced today that Jackson Health System has selected the Company as its strategic partner to implement MedAssets' transformational approach to significantly lower supply costs, drive operational efficiencies and engage physicians in the cost and clinical utilization management improvement process.
Ching-Ling (Ellen) Lien, PhD, an investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded nearly $1.7 million, over a four year period, from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the molecular and cellular mechanisms of the heart's circulatory system.
Pfizer Inc. announced today top-line results from ORAL Start (A3921069), a Phase 3 study of the investigational agent tofacitinib, a novel, oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).
› Verified 2 days ago
Karly Thompson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 E Piccadilly St Ste 11, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Rachel Baez, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Raab C Reibach, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Bellview Ave, Winchester, VA 22601 Phone: 540-542-0200 | |
Mrs. Anita Lucile Conrad, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Lauck Dr, Winchester, Winchester, VA 22603 Phone: 540-667-7830 Fax: 540-535-2048 | |
Kelly Hancock, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Joni Vercammen, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Molly Rose Connor, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 W Cork St, Winchester, VA 22601 Phone: 540-536-5114 |